Fortrea HoldingsNASDAQ: FTRE

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

20 June 2023

Next earnings report:

14 August 2024

Last dividends:

N/A

Next dividends:

N/A
$2.12 B
-41%vs. 3y high
83%vs. sector
-vs. 3y high
-vs. sector
-41%vs. 3y high
47%vs. sector
-41%vs. 3y high
18%vs. sector

Price

after hours | Wed, 03 Jul 2024 17:13:16 GMT
$23.70-$0.10(-0.40%)

Dividend

No data over the past 3 years
$662.10 M$688.41 M
$662.10 M-$101.00 M

Analysts recommendations

Institutional Ownership

FTRE Latest News

Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
globenewswire.com19 June 2024 Sentiment: -

DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will participate in a virtual fireside chat hosted by Elizabeth Anderson, senior managing director at Evercore ISI, to discuss Fortrea's business on Thursday, June 20, 2024 at 2:00 pm ET.

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
globenewswire.com04 June 2024 Sentiment: POSITIVE

DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare and industrial growth companies.

Fortrea to Present at the Jefferies Global Healthcare Conference
globenewswire.com03 June 2024 Sentiment: POSITIVE

DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am ET.

Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
globenewswire.com30 May 2024 Sentiment: POSITIVE

Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials

Fortrea Appoints Machelle Sanders to Board of Directors
globenewswire.com16 May 2024 Sentiment: POSITIVE

Fortrea (Nasdaq: FTRE) announced today that Machelle Sanders has been appointed to the Company's Board of Directors. Ms. Sanders, who has over 30 years of experience in pharmaceutical and biotechnology companies, currently serves as North Carolina's Secretary of Commerce.

Fortrea Holdings (FTRE) Q1 2024 Earnings Call Transcript
Seeking Alpha13 May 2024 Sentiment: POSITIVE

Fortrea Holdings Inc. (NASDAQ:FTRE) Q1 2024 Earnings Conference Call on May 13, 2024 at 8:00 AM ET featuring Tom Pike as Chairman and CEO, Jill McConnell as CFO, and Hima Inguva as Head of Investor Relations and Corporate Development. Conference call participants include analysts from Jefferies, Evercore, Citi, Baird, William Blair, Bank of America, and JP Morgan. Operator begins the call by welcoming attendees to the Fortrea first quarter 2024 earnings conference call.

Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewsWire06 May 2024 Sentiment: NEGATIVE

Fortrea (Nasdaq: FTRE), a top contract research organization (CRO), has postponed the release of its first quarter 2024 financial results due to accounting and discontinued operations issues related to the recent agreement to sell assets from the Enabling Services segment.

Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
GlobeNewsWire11 April 2024 Sentiment: POSITIVE

Fortrea, a top global contract research organization, revealed that it will announce its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. A conference call will be held at 9:00 am ET that day to discuss the results and answer questions.

Fortrea Holdings Inc. (FTRE) Q4 2023 Earnings Call Transcript
Seeking Alpha11 March 2024 Sentiment: POSITIVE

Fortrea Holdings Inc. (NASDAQ:FTRE ) Q4 2023 Earnings Conference Call March 11, 2024 9:00 AM ET Company Participants Hima Inguva - Head of Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Conference Call Participants David Windley - Jefferies Elizabeth Anderson - Evercore Max Smock - William Blair Justin Bowers - DB Patrick Donnelly - Citi Derik De Bruin - Bank of America Operator Ladies and gentlemen, thank you for standing by. Welcome to Fortrea Fourth Quarter 2023 Earnings Conference Call.

Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today
The Motley Fool13 November 2023 Sentiment: POSITIVE

The contract healthcare research specialist posted quarterly earnings Monday morning. It handily beat analyst expectations on both the top and bottom lines.

What type of business is Fortrea Holdings?

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.

What sector is Fortrea Holdings in?

Fortrea Holdings is in the Healthcare sector

What industry is Fortrea Holdings in?

Fortrea Holdings is in the Biotechnology industry

What country is Fortrea Holdings from?

Fortrea Holdings is headquartered in United States

When did Fortrea Holdings go public?

Fortrea Holdings initial public offering (IPO) was on 20 June 2023

What is Fortrea Holdings website?

https://www.fortrea.com

Is Fortrea Holdings in the S&P 500?

No, Fortrea Holdings is not included in the S&P 500 index

Is Fortrea Holdings in the NASDAQ 100?

No, Fortrea Holdings is not included in the NASDAQ 100 index

Is Fortrea Holdings in the Dow Jones?

No, Fortrea Holdings is not included in the Dow Jones index

When does Fortrea Holdings report earnings?

The next expected earnings date for Fortrea Holdings is 14 August 2024